---
title: "NNOX.US (NNOX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NNOX.US/news.md"
symbol: "NNOX.US"
name: "NNOX.US"
parent: "https://longbridge.com/en/quote/NNOX.US.md"
datetime: "2026-03-13T05:09:55.931Z"
locales:
  - [en](https://longbridge.com/en/quote/NNOX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NNOX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NNOX.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/NNOX.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/NNOX.US/news.md)


# NNOX.US (NNOX.US) — Related News

### [Nanox partners with Imperial Imaging for U.S. Southeast expansion, targeting orthopedic segment across six states.](https://longbridge.com/en/news/277628460.md)
*2026-03-03T13:02:00.000Z*
> Nanox has bolstered its commercial rollout across six states in the U.S. Southeast by securing an agreement with Imperia

### [NanoXplore (TSX:GRA) Q2 Loss Extends Profitability Debate Despite Bullish Growth Forecasts](https://longbridge.com/en/news/275826271.md)
*2026-02-13T00:12:38.000Z*
> NanoXplore (TSX:GRA) reported Q2 2026 revenue of CA$27.6 million and a net loss of CA$3.8 million, raising concerns abou

### [NanoXplore Q2-2026 Advanced Materials, Plastics and Composite Products adjusted EBITDA drops 86% to CAD 0.18 million](https://longbridge.com/en/news/275515261.md)
*2026-02-10T21:46:24.000Z*
### [NanoXplore reported Q2-2026 results: $27.58M revenues (17% decrease), $3.84M loss, $224k EBITDA. Strategic decision to not pursue $100M initiative.](https://longbridge.com/en/news/275517685.md)
*2026-02-10T21:46:22.000Z*
> NanoXplore Inc. reported Q2-2026 results with revenues of $27.58M, a 17% decrease year-over-year, and a loss of $3.84M. 

### [](https://longbridge.com/en/news/274669942.md)
*2026-02-03T14:07:46.000Z*
> Due to the approval of its imaging enhancement function by the U.S. Food and Drug Administration, Nano-X Imaging's stock

### [Nanox Receives FDA 510(k) Clearance for TAP2D New Image Enhancement Capability for Nanox.ARC and Nanox.ARC X Systems | NNOX Stock News](https://longbridge.com/en/news/274664261.md)
*2026-02-03T05:15:00.000Z*
> Nanox Imaging Ltd has received FDA 510(k) clearance for its TAP2D image enhancement capability for the Nanox.ARC and Nan

### [16:06 ET
			
			
				Disrupting Biotech: Jurek Kozyra Unveils DNA Nanorobots That Could Cure the Incurable](https://longbridge.com/en/news/272746120.md)
*2026-01-15T21:07:04.000Z*
> Jurek Kozyra, CEO of Nanovery, discusses on the Disruption Interruption podcast how DNA nanorobots and AI are revolution